Literature DB >> 7846125

Integrated control of cell proliferation and cell death by the c-myc oncogene.

G Evan1, E Harrington, A Fanidi, H Land, B Amati, M Bennett.   

Abstract

Regulation of multicellular architecture involves a dynamic equilibrium between cell proliferation, differentiation with consequent growth arrest, and cell death. Apoptosis is one particular form of active cell death that is extremely rapid and characterized by auto-destruction of chromatin, cellular blebbing and condensation, and vesicularization of internal components. The c-myc proto-oncogene encodes an essential component of the cell's proliferative machinery and its deregulated expression is implicated in most neoplasms. Intriguingly, c-myc can also act as a potent inducer of apoptosis. Myc-induced apoptosis occurs only in cells deprived of growth factors or forcibly arrested with cytostatic drugs. Myc-induced apoptosis is dependent upon the level at which it is expressed and deletion mapping shows that regions of c-Myc required for apoptosis overlap with regions necessary for co-transformation, autoregulation, inhibition of differentiation, transcriptional activation and sequence-specific DNA binding. Moreover, induction of apoptosis by c-Myc requires association with c-Myc's heterologous partner, Max. All of this strongly implies that c-Myc drives apoptosis through a transcriptional mechanism: presumably by modulation of target genes. Two simple models can be invoked to explain the induction of apoptosis by c-Myc. One holds that death arises from a conflict in growth signals which is generated by the inappropriate or unscheduled expression of c-Myc under conditions that would normally promote growth arrest. In this 'Conflict' model, induction of apoptosis is not a normal function of c-Myc but a pathological manifestation of its deregulation. It thus has significance only for models of carcinogenic progression in which myc genes are invariably disrupted.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7846125     DOI: 10.1098/rstb.1994.0105

Source DB:  PubMed          Journal:  Philos Trans R Soc Lond B Biol Sci        ISSN: 0962-8436            Impact factor:   6.237


  33 in total

1.  Interference with the expression of a novel human polycomb protein, hPc2, results in cellular transformation and apoptosis.

Authors:  D P Satijn; D J Olson; J van der Vlag; K M Hamer; C Lambrechts; H Masselink; M J Gunster; R G Sewalt; R van Driel; A P Otte
Journal:  Mol Cell Biol       Date:  1997-10       Impact factor: 4.272

Review 2.  The fascia of the limbs and back--a review.

Authors:  Mike Benjamin
Journal:  J Anat       Date:  2009-01       Impact factor: 2.610

3.  c-Myc and caspase-2 are involved in activating Bax during cytotoxic drug-induced apoptosis.

Authors:  Xuefang Cao; Richard L Bennett; W Stratford May
Journal:  J Biol Chem       Date:  2008-03-28       Impact factor: 5.157

4.  Expression analysis of genes encoding double B-box zinc finger proteins in maize.

Authors:  Wenlan Li; Jingchao Wang; Qi Sun; Wencai Li; Yanli Yu; Meng Zhao; Zhaodong Meng
Journal:  Funct Integr Genomics       Date:  2017-05-08       Impact factor: 3.410

5.  Alterations in exon 1 of c-myc and expression of p62c-myc in cervical squamous cell carcinoma.

Authors:  J J O'Leary; R J Landers; M Crowley; I Healy; W F Kealy; J Hogan; C T Doyle
Journal:  J Clin Pathol       Date:  1997-11       Impact factor: 3.411

6.  Evaluation of Ki-67 and Bcl-2 antigen expression in breast carcinomas of women treated with raloxifene.

Authors:  P V Lopes-Costa; A R dos Santos; L G dos Santos; B B da Silva
Journal:  Cell Prolif       Date:  2010-04       Impact factor: 6.831

7.  Induction of Myc-intron-binding polypeptides MIBP1 and RFX1 during retinoic acid-mediated differentiation of haemopoietic cells.

Authors:  M Zajac-Kaye; N Ben-Baruch; E Kastanos; F J Kaye; C Allegra
Journal:  Biochem J       Date:  2000-02-01       Impact factor: 3.857

8.  Myc potentiates apoptosis by stimulating Bax activity at the mitochondria.

Authors:  E L Soucie; M G Annis; J Sedivy; J Filmus; B Leber; D W Andrews; L Z Penn
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

9.  MYC needs MNT.

Authors:  Jason M Link; Peter J Hurlin
Journal:  Cell Cycle       Date:  2013-01-16       Impact factor: 4.534

Review 10.  The ups and downs of Myc biology.

Authors:  Laura Soucek; Gerard I Evan
Journal:  Curr Opin Genet Dev       Date:  2009-12-03       Impact factor: 5.578

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.